Mayo Clinic Intravitreal Injection Clinic

Overview

About this study

The purpose of this study is to collect data on the safety of not performing retinal imaging (e.g., optical coherence tomography, OCT) for patients receiving intravitreal injections. Analyze the outcomes, safety, and patient satisfaction of the Mayo Clinic Rochester Injection Clinic, where patients do not have retinal imaging or dilated eye examinations at every visit.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age 18 to ≤ 105.
Patients who have received ≥ 1 intravitreal injection at the Mayo Clinic Rochester Injection Clinic.

Exclusion Criteria:

Patients who have never received an intravitreal injection at the Mayo Clinic Rochester Injection Clinic.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/6/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Brittni Scruggs, M.D., Ph.D.	Open for enrollment	Contact information: Suzanne Wernimont CCRP (507) 538-8119 Wernimont.Suzanne@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Brittni Scruggs, M.D., Ph.D.

Open for enrollment

Contact information:

Suzanne Wernimont CCRP

(507) 538-8119

Wernimont.Suzanne@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials